ease (CAD) include overt, typical chest pain syndromes, atypical symptomatic ischemia, and asymptomatic or unnoticed ischemia. Previously unrecognized CAD may become apparent with abnormalities on a resting electrocardiogram including electrocardiographic left ventricular hypertrophy, nonspecific ST and T wave abnormalities, Q waves and interventricular conduction delays including bundle branch block. Silent CAD may also be recognized during an asymptomatic positive stress test.
For several years, it has been postulated that people with diabetes have a higher prevalence of asymptomatic or atypical CAD. The literature is far from clear on this point. What appears undeniable is that diabetes is an independent risk factor for the development of early CAD. In addition, the diagnosis of type 2 diabetes carries with it an increased risk of abnormal lipid profiles and hypertension (Syndrome X), both of which are independent risk factors for CAD. People with type 1 diabetes often lack other associated risk factors for atherosclerosis. Duration of diabetes seems to be the predominant predictor of CAD in these patients.
Silent myocardial ischemia was examined in the Framingham study. 1 In this cohort of 5,209 men and women, unrecognized anterior and inferior myocardial infarctions (MIs) were established by comparing biennial electrocardiograms.
More than 25% of all MIs in the Framingham cohort were discovered retrospectively, only after clear evidence of myocardial damage was noted on these routine electrocardiograms. Of these unrecognized MIs, 48% in men and 46% in women were actually silent. The remaining unrecognized MIs were so atypical that neither the patient nor the attending physician entertained MI as a possible diagnosis.
Women had a higher incidence of unrecognized infarction than men (35 vs. 28%) at all age levels. Hypertension was the only CAD risk factor, in both men and women, that was statistically correlated with unrecognized MI. This was a consistent finding even after excluding those patients with coexisting diabetes. In the cohort with diabetes, MI was unrecognized in 39% of men, a clear excess. In women, only 17% of the MIs were unrecognized, less than half the rate noted in the nondiabetic population. The authors offered no theory for these divergent findings.
Other studies have demonstrated an increased incidence of unrecognized CAD in patients with diabetes. In a casecontrol study, 41 T.T. had no known history of diabetic retinopathy or nephropathy. She also denied resting tachycardia, orthostatic lightheadedness, early satiety, early morning nausea, changes in bowel habits, or postprandial sweating. She did note a history of depression, which was treated with counseling and medication. She also noted menstrual irregularity, dysmenorrhea, and premenstrual emotional lability. She had been treated with oral contraceptives in the past, but had discontinued these 6-8 months ago.
Her glycemic control had never been optimal despite a multiple-dose insulin program. Her hemoglobin A 1c (A1C) levels had typically been in the 8-9% range.
Exam revealed a moderately overweight (BMI 27 kg/m 2 ) woman with a blood pressure of 138/85 mmHg with no orthostatic change and a resting pulse of 72 with no change with Valsalva maneuver. Lower extremity exam showed normal skin pigmentation, easily palpable dorsalis pedis pulses, but decreased position sense as well as decreased sensation to 10-g monofilament testing.
Laboratory testing revealed an A1C of 8.2% (normal <6.5%); an albumin-tocreatinine ratio of 25 g/mg (normal <30 g/mg); and normal serum creatinine, complete blood count, total protein, sedimentation rate, and thyroid stimulating hormone.
When asked to bring in all over-thecounter and prescribed medications previously and currently used, the patient acknowledged taking pyridoxine (vitamin B6), a medication that she had started after reading on the Internet that it could help in the treatment of both premenstrual syndrome and carpal tunnel syndrome. She reported taking pyridoxine at a dosage of 200-500 mg daily for the past 6 months. Peripheral neuropathy may also be associated with malignancy, such as lymphoma or bronchogenic or gastric carcinoma, and with infectious/inflammatory processes, such as monoclonal paraproteinemias, HIV, lyme disease, borreliosis, or leprosy. In addition, it may also be associated with a variety of familial syndromes, such as CharcoatMarie-Tooth syndrome. 1 Providers must also recognize that over-the-counter remedies can have side effects including, in this instance, peripheral neuropathy. High-dose pyridoxine (B6) has been reported to cause sensory dysfunction and ataxia that improves after the vitamin is discontinued. Although initially believed to be related to mega-dose ingestion, 2 these symptoms have been reported in lowerdose users including those taking as little as 200 mg/day.
3 Most patients note improvement or complete resolution of symptoms with discontinuation of pyridoxine. T.T. had substantial improvement within just 2-3 weeks of discontinuing pyridoxine.
Although neuropathy is a common complication of diabetes, it is important to be aware of other potential etiologies of neuropathy in diabetic patients to avoid missing an important diagnostic clue for a treatable condition. A careful 2. A thorough history and appropriate laboratory testing are needed to ensure completeness of the search for these etiologies. This should include a review of all over-the-counter medications being used about which patients may not initially volunteer information. 3. Several medications commonly used by people with diabetes may be associated with neuropathy. 4. Evidence of a beneficial role for pyridoxine in the treatment of neuropathy is inconclusive.
history should be obtained including use of both over-the-counter and prescription medications because commonly used agents can be associated with neuropathy. [4] [5] [6] Treatment of specific problems, such as carpal tunnel syndrome, with pyridoxine has been thought at times to be beneficial, 7 but not all data have supported this. 8 Strongly encouraging patients to bring in all their medications can be a simple but helpful tool in making a more accurate diagnosis and effective therapeutic intervention.
Clinical Pearls
1. The differential diagnosis of peripheral neuropathy in diabetic patients is not limited to diabetes, but rather may have a variety of metabolic, toxic, inflammatory, malignant, infectious, and familial causes.
